RxDoctor Payments Data

James Michino

Oral and Maxillofacial Surgery · Honolulu, HINPI 1730494931

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,295 of the $5,250 with a category attached, or 62.8%. 9 manufacturers reported payments, led by Nobel Biocare USA at 43.5% of the total. Reporting peaked in 2024 at $2,030 and has fallen 63.8% since, to $736 in 2025.

$5,250in general payments, 2019–2025

Across 73 payments — averaging $71.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nobel Biocare USA$2K
  • Midmark Corporation$2K
  • Patterson Companies, Inc.$264
  • Hu-friedy Mfg. Co., LLC$251
  • Stryker$175
  • Kls-martin L.p.$88
  • plus $159 from 3 others

What the payments were for

  • Travel & lodging$1,67932%
  • Food & beverage$3,29563%
  • Education$2765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,250 in reported general payments places this provider in the 80th percentile of 38 oral and maxillofacial surgery providers in Hawaii.

See all oral and maxillofacial surgery providers in Hawaii

Medicare billing

Part B allowed, 2024
$1,767
Medicare patients
12
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorhexidine Gluconate104$498
Amoxicillin103$335
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$330
Ibuprofen104$292
Clindamycin Hcl20$242
Acetaminophen-CodeineAcetaminophen With Codeine26$194

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →